Health Alzheimer's Disease study plans to study 2,000 volunteers' brain scans and blood work to identify biomarkers of ...

An Alzheimer’s treatment from idea to market can take up to 20 years. After a long hiatus, the U.S. Food and Drug ...

Recent research is looking at the way in which cardiovascular issue may play into the development of dementia, with one study suggesting that heparin, a common anticoagulant, may help delay ...

Alzamend Neuro Announces Full Data Set from Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s ...

Professor Craig Ritchie also believes things will move so quickly that advanced cases of dementia in the future could almost ...

Professor Craig Ritchie, of the University of Edinburgh, said he expects a cure for Alzheimer's in 10 years and that managing ...

NHS patients are set to miss out on new Alzheimer’s drugs, experts warn ...

Heparin treatment was associated with a delayed diagnosis of Alzheimer's dementia, electronic health records in two U.S.

By obtaining high-resolution images of Alzheimer’s disease-affected brain cells as the condition progresses, researchers have identified the specific neurons that are damaged. The information the ...

A recent study suggests that a drug approved for the treatment of seizures may also help treat Alzheimer's in people who do ...

SCOTLAND has a “golden opportunity” to lead the way in dementia care if the NHS is given the go-ahead to use a new kind of ...